{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:39:02Z","timestamp":1778125142332,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T00:00:00Z","timestamp":1621728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T00:00:00Z","timestamp":1621728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00404-021-06096-6","type":"journal-article","created":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T09:02:35Z","timestamp":1621760555000},"page":"1569-1576","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of surgical and oncologic outcomes in patients with clear cell ovarian carcinoma associated with and without endometriosis"],"prefix":"10.1007","volume":"304","author":[{"given":"Ruja","family":"Charatsingha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchanan","family":"Hanamornroongruang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mongkol","family":"Benjapibal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suwanit","family":"Therasakvichya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atthapon","family":"Jaishuen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pattama","family":"Chaopotong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pisutt","family":"Srichaikul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1913-6613","authenticated-orcid":false,"given":"Nida","family":"Jareemit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,23]]},"reference":[{"issue":"6","key":"6096_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"6096_CR2","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.3802\/jgo.2016.27.e65","volume":"27","author":"S Wilailak","year":"2016","unstructured":"Wilailak S, Lertchaipattanakul N (2016) The epidemiologic status of gynecologic cancer in Thailand. J Gynecol Oncol 27(6):e65","journal-title":"J Gynecol Oncol"},{"issue":"11","key":"6096_CR3","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1002\/ijc.30676","volume":"140","author":"SB Coburn","year":"2017","unstructured":"Coburn SB, Bray F, Sherman ME, Trabert B (2017) International patterns and trends in ovarian cancer incidence, overall and by histologic subtype. Int J Cancer 140(11):2451\u20132460","journal-title":"Int J Cancer"},{"issue":"3","key":"6096_CR4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ygyno.2012.04.021","volume":"126","author":"MG del Carmen","year":"2012","unstructured":"del Carmen MG, Birrer M, Schorge JO (2012) Clear cell carcinoma of the ovary: a review of the literature. Gynecol Oncol 126(3):481\u2013490","journal-title":"Gynecol Oncol"},{"issue":"3","key":"6096_CR5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ygyno.2008.02.006","volume":"109","author":"JK Chan","year":"2008","unstructured":"Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS (2008) Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol 109(3):370\u2013376","journal-title":"Gynecol Oncol"},{"issue":"3","key":"6096_CR6","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.ygyno.2014.01.012","volume":"132","author":"M Davis","year":"2014","unstructured":"Davis M, Rauh-Hain JA, Andrade C, Boruta DM 2nd, Schorge JO, Horowitz NS et al (2014) Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary. Gynecol Oncol 132(3):760\u2013766","journal-title":"Gynecol Oncol"},{"issue":"6","key":"6096_CR7","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.fertnstert.2014.08.008","volume":"102","author":"S Ye","year":"2014","unstructured":"Ye S, Yang J, You Y, Cao D, Bai H, Lang J et al (2014) Comparative study of ovarian clear cell carcinoma with and without endometriosis in People\u2019s Republic of China. Fertil Steril 102(6):1656\u20131662","journal-title":"Fertil Steril"},{"issue":"3","key":"6096_CR8","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ygyno.2014.03.017","volume":"133","author":"G Scarfone","year":"2014","unstructured":"Scarfone G, Bergamini A, Noli S, Villa A, Cipriani S, Taccagni G et al (2014) Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study. Gynecol Oncol 133(3):480\u2013484","journal-title":"Gynecol Oncol"},{"key":"6096_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000052873","volume":"50","author":"H Yoshikawa","year":"2000","unstructured":"Yoshikawa H, Jimbo H, Okada S, Matsumoto K, Onda T, Yasugi T et al (2000) Prevalence of endometriosis in ovarian cancer. Gynecol Obstet Invest 50:11\u201317 (Suppl 1)","journal-title":"Gynecol Obstet Invest"},{"issue":"3","key":"6096_CR10","first-page":"1947","volume":"19","author":"H Liu","year":"2020","unstructured":"Liu H, Xu Y, Ji J, Dong R, Qiu H, Dai X (2020) Prognosis of ovarian clear cell cancer compared with other epithelial cancer types: a population-based analysis. Oncol Lett 19(3):1947\u20131957","journal-title":"Oncol Lett"},{"issue":"7","key":"6096_CR11","doi-asserted-by":"publisher","first-page":"e0133498","DOI":"10.1371\/journal.pone.0133498","volume":"10","author":"S Ye","year":"2015","unstructured":"Ye S, Yang J, You Y, Cao D, Huang H, Wu M et al (2015) Comparison of clinical characteristic and prognosis between ovarian clear cell carcinoma and serous carcinoma: a 10-year cohort study of Chinese patients. PLoS ONE 10(7):e0133498","journal-title":"PLoS ONE"},{"issue":"2","key":"6096_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jfma.2017.03.007","volume":"117","author":"FC Ku","year":"2018","unstructured":"Ku FC, Wu RC, Yang LY, Tang YH, Chang WY, Yang JE et al (2018) Clear cell carcinomas of the ovary have poorer outcomes compared with serous carcinomas: results from a single-center Taiwanese study. J Formos Med Assoc 117(2):117\u2013125","journal-title":"J Formos Med Assoc"},{"key":"6096_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12935-015-0267-0","volume":"15","author":"S Matsuzaki","year":"2015","unstructured":"Matsuzaki S, Yoshino K, Ueda Y, Matsuzaki S, Kakuda M, Okazawa A et al (2015) Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives. Cancer Cell Int 15:117","journal-title":"Cancer Cell Int"},{"issue":"11","key":"6096_CR14","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1002\/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5","volume":"88","author":"T Sugiyama","year":"2000","unstructured":"Sugiyama T, Kamura T, Kigawa J, Terakawa N, Kikuchi Y, Kita T et al (2000) Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 88(11):2584\u20132589","journal-title":"Cancer"},{"issue":"4","key":"6096_CR15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/IGC.0000000000000100","volume":"24","author":"FR Nezhat","year":"2014","unstructured":"Nezhat FR, Pejovic T, Reis FM, Guo SW (2014) The link between endometriosis and ovarian cancer: clinical implications. Int J Gynecol Cancer 24(4):623\u2013628","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"6096_CR16","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.18632\/oncotarget.13907","volume":"8","author":"B Son","year":"2017","unstructured":"Son B, Lee S, Youn H, Kim E, Kim W, Youn B (2017) The role of tumor microenvironment in therapeutic resistance. Oncotarget 8(3):3933\u20133945","journal-title":"Oncotarget"},{"issue":"2","key":"6096_CR17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ygyno.2017.08.003","volume":"147","author":"A Melamed","year":"2017","unstructured":"Melamed A, Manning-Geist B, Bregar AJ, Diver EJ, Goodman A, Del Carmen MG et al (2017) Associations between residual disease and survival in epithelial ovarian cancer by histologic type. Gynecol Oncol 147(2):250\u2013256","journal-title":"Gynecol Oncol"},{"issue":"3","key":"6096_CR18","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ygyno.2008.05.025","volume":"110","author":"JP Orezzoli","year":"2008","unstructured":"Orezzoli JP, Russell AH, Oliva E, Del Carmen MG, Eichhorn J, Fuller AF (2008) Prognostic implication of endometriosis in clear cell carcinoma of the ovary. Gynecol Oncol 110(3):336\u2013344","journal-title":"Gynecol Oncol"},{"issue":"1","key":"6096_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/IGC.0000000000001136","volume":"28","author":"JY Park","year":"2018","unstructured":"Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT et al (2018) Significance of ovarian endometriosis on the prognosis of ovarian clear cell carcinoma. Int J Gynecol Cancer 28(1):11\u201318","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"6096_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13048-018-0425-9","volume":"11","author":"T Zhao","year":"2018","unstructured":"Zhao T, Shao Y, Liu Y, Wang X, Guan L, Lu Y (2018) Endometriosis does not confer improved prognosis in ovarian clear cell carcinoma: a retrospective study at a single institute. J Ovarian Res 11(1):53","journal-title":"J Ovarian Res"},{"key":"6096_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/archsurg.1925.01120100007001","volume":"10","author":"JA Sampson","year":"1925","unstructured":"Sampson JA (1925) Endometrial carcinoma of ovary arising in endometrial tissue in that organ. Arch Surg 10:1\u201372","journal-title":"Arch Surg"},{"issue":"3","key":"6096_CR22","first-page":"283","volume":"2","author":"RB Scott","year":"1953","unstructured":"Scott RB (1953) Malignant changes in endometriosis. Obstet Gynecol 2(3):283\u2013289","journal-title":"Obstet Gynecol"},{"issue":"2","key":"6096_CR23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228\u2013247","journal-title":"Eur J Cancer"},{"issue":"3","key":"6096_CR24","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1210\/en.2018-00794","volume":"160","author":"SE Bulun","year":"2019","unstructured":"Bulun SE, Wan Y, Matei D (2019) Epithelial mutations in endometriosis: link to ovarian cancer. Endocrinology 160(3):626\u2013638","journal-title":"Endocrinology"},{"issue":"1","key":"6096_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1055\/s-0036-1597120","volume":"35","author":"MA Wilbur","year":"2017","unstructured":"Wilbur MA, Shih IM, Segars JH, Fader AN (2017) Cancer implications for patients with endometriosis. Semin Reprod Med 35(1):110\u2013116","journal-title":"Semin Reprod Med"},{"issue":"4","key":"6096_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1470-2045(11)70404-1","volume":"13","author":"CL Pearce","year":"2012","unstructured":"Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM et al (2012) Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 13(4):385\u2013394","journal-title":"Lancet Oncol"},{"issue":"16","key":"6096_CR27","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","volume":"363","author":"KC Wiegand","year":"2010","unstructured":"Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T et al (2010) ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 363(16):1532\u20131543","journal-title":"N Engl J Med"},{"key":"6096_CR28","doi-asserted-by":"publisher","first-page":"6118","DOI":"10.1038\/ncomms7118","volume":"6","author":"RL Chandler","year":"2015","unstructured":"Chandler RL, Damrauer JS, Raab JR, Schisler JC, Wilkerson MD, Didion JP et al (2015) Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling. Nat Commun 6:6118","journal-title":"Nat Commun"},{"issue":"24","key":"6096_CR29","first-page":"7052","volume":"60","author":"N Sato","year":"2000","unstructured":"Sato N, Tsunoda H, Nishida M, Morishita Y, Takimoto Y, Kubo T et al (2000) Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 60(24):7052\u20137056","journal-title":"Cancer Res"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-021-06096-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-021-06096-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-021-06096-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T15:10:49Z","timestamp":1635433849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-021-06096-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,23]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6096"],"URL":"https:\/\/doi.org\/10.1007\/s00404-021-06096-6","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,23]]},"assertion":[{"value":"5 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no personal or professional conflicts of interest, and no financial support from the companies that produce and\/or distribute the drugs, devices, or materials described in this report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Siriraj Institutional Review Board (SIRB) of the Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand in March 2018 (Number Si147\/2018).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Consent statement is not applicable for this retrospective study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}